DESCRIPTION
id: 94172cd5-b942-40c9-8feb-b7917b2bee8f
displayName: DESCRIPTION SECTION
FDA Article Code: 34089-3
Hydrocodone bitartrate and acetaminophen is supplied in tablet form for oral administration.
Hydrocodone bitartrate is an opioid analgesic and antitussive and occurs as fine, white crystals or as a crystalline powder. It is affected by light. The chemical name is 4,5α-epoxy-3-methoxy-17-methylmorphinan-6-one tartrate (1:1) hydrate (2:5). It has the following structural formula:
Acetaminophen, 4′-hydroxyacetanilide, a slightly bitter, white, odorless, crystalline powder, is a non-opiate, non-salicylate analgesic and antipyretic. It has the following structural formula:
Each tablet contains:
Hydrocodone Bitartrate 10 mg
Acetaminophen 660 mg
In addition each tablet contains the following inactive ingredients: colloidal silicon dioxide, corn starch (pregelatinized), croscarmellose sodium, crospovidone, magnesium stearate, microcrystalline cellulose, povidone and stearic acid.
Meets USP Dissolution Test 2.
CLINICAL PHARMACOLOGY
id: e060fa75-2587-4a60-92d4-c8acd3070ffa
displayName: CLINICAL PHARMACOLOGY SECTION
FDA Article Code: 34090-1
Hydrocodone is a semisynthetic narcotic analgesic and antitussive with multiple actions qualitatively similar to those of codeine. Most of these involve the central nervous system and smooth muscle. The precise mechanism of action of hydrocodone and other opiates is not known, although it is believed to relate to the existence of opiate receptors in the central nervous system. In addition to analgesia, narcotics may produce drowsiness, changes in mood and mental clouding.
The analgesic action of acetaminophen involves peripheral influences, but the specific mechanism is as yet undetermined. Antipyretic activity is mediated through hypothalamic heat regulating centers. Acetaminophen inhibits prostaglandin synthetase. Therapeutic doses of acetaminophen have negligible effects on the cardiovascular or respiratory systems; however, toxic doses may cause circulatory failure and rapid, shallow breathing.
INDICATIONS AND USAGE
id: 760846d4-3b64-45cc-a76e-ba51385a8ec5
displayName: INDICATIONS & USAGE SECTION
FDA Article Code: 34067-9
Hydrocodone bitartrate and acetaminophen tablets are indicated for the relief of moderate to moderately severe pain.
CONTRAINDICATIONS
id: 941f5eb8-1f97-43be-bd5f-73ebbfd3bfe8
displayName: CONTRAINDICATIONS SECTION
FDA Article Code: 34070-3
This product should not be administered to patients who have previously exhibited hypersensitivity to hydrocodone or acetaminophen.
Patients known to be hypersensitive to other opioids may exhibit cross-sensitivity to hydrocodone.
ADVERSE REACTIONS
id: 556dadea-fd47-4c8b-8f39-2776b1262b92
displayName: ADVERSE REACTIONS SECTION
FDA Article Code: 34084-4
The most frequently reported adverse reactions are light-headedness, dizziness, sedation, nausea and vomiting. These effects seem to be more prominent in ambulatory than in non-ambulatory patients, and some of these adverse reactions may be alleviated if the patient lies down.
OVERDOSAGE
id: dc4ec53b-e4cf-49ba-b0c9-ee964829c030
displayName: OVERDOSAGE SECTION
FDA Article Code: 34088-5
Following an acute overdosage, toxicity may result from hydrocodone or acetaminophen.
DOSAGE AND ADMINISTRATION
id: c0f927c3-e8e6-4439-8bb9-f667e5336c2c
displayName: DOSAGE & ADMINISTRATION SECTION
FDA Article Code: 34068-7
Dosage should be adjusted according to severity of pain and response of the patient. However, it should be kept in mind that tolerance to hydrocodone can develop with continued use and that the incidence of untoward effects is dose related.
The usual adult dosage is one tablet every four to six hours as needed for pain. The total daily dosage should not exceed 5 tablets.
HOW SUPPLIED
id: b47af63b-fec4-48d7-a101-7377d277bd68
displayName: HOW SUPPLIED SECTION
FDA Article Code: 34069-5
Hydrocodone bitartrate and acetaminophen tablets USP, 10 mg/660 mg are white, capsule shaped tablets debossed with “567” on one side and scored on the other side.
Bottles of 60 Tablets
NDC 21695-508-60
Store at controlled room temperature, 20°-25°C (68°-77°F). [See USP.]
Dispense in a tight, light-resistant container as defined in the USP. Protect from light.
A Schedule Class III Narcotic.
Manufactured by:
Watson Laboratories, Inc.
Corona, CA 92880 USA
Distributed by:
Watson Pharma, Inc.
Rev date: 12/06
7282
Repackaged by:
Rebel Distributors Corp
Thousand Oaks, CA 91320
Principal Display Panel
id: 7ac47d7c-db2b-45be-a93f-59df40c43735
displayName: PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
FDA Article Code: 51945-4
